OriGene Technologies, Inc. Sustainability Profile
OriGene Technologies, Inc., a leading biotechnology company headquartered in the United States, has been at the forefront of molecular biology since its founding in 1996. With a strong presence in North America, Europe, and Asia, OriGene focuses on providing innovative solutions in gene expression, protein production, and antibody development. The company is renowned for its extensive portfolio of high-quality products, including cDNA clones, antibodies, and gene expression assays, which are designed to accelerate research in genomics and proteomics. OriGene's commitment to quality and innovation has positioned it as a trusted partner for researchers and institutions worldwide. Notable achievements include the development of unique technologies that enhance the accuracy and efficiency of gene analysis, solidifying OriGene's reputation as a key player in the biotechnology industry.
DitchCarbon Score
How does OriGene Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OriGene Technologies, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OriGene Technologies, Inc.'s reported carbon emissions
OriGene Technologies, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that OriGene may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the biotechnology industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, it is unclear how OriGene Technologies aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
How Carbon Intensive is OriGene Technologies, Inc.'s Industry?
How Carbon Intensive is OriGene Technologies, Inc.'s Location?
OriGene Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OriGene Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.